[Adalimumab]
Ann Dermatol Venereol
.
2019 Jun-Jul;146(6-7):478-482.
doi: 10.1016/j.annder.2019.04.012.
Epub 2019 Jun 13.
[Article in French]
Authors
F Aubin
1
;
Groupe de recherche sur le psoriasis de la Société française de dermatologie
2
Affiliations
1
Service de dermatologie, CHU de Besançon, 3, boulevard Fleming, 25030 Besançon cedex, France. Electronic address: francois.aubin@univ-fcomte.fr.
2
Service de dermatologie, CHU de Besançon, 3, boulevard Fleming, 25030 Besançon cedex, France.
PMID:
31202514
DOI:
10.1016/j.annder.2019.04.012
No abstract available
MeSH terms
Adalimumab / pharmacology*
Anti-Inflammatory Agents / pharmacology*
Contraindications, Drug
Drug Monitoring
Humans
Psoriasis / drug therapy
Substances
Anti-Inflammatory Agents
Adalimumab